| 12458695 |
Dosing regimens and related compositions and methods |
Federico Grossi, Cedric Francois, Patrick Johnson, Carolina Vega |
2025-11-04 |
|
| 12290566 |
Dosing regimens and related compositions and methods |
Federico Grossi, Cedric Francois, Patrick Johnson, Carolina Vega |
2025-05-06 |
|
| 11903994 |
Dosing regimens |
Federico Grossi, Cedric Francois |
2024-02-20 |
$166,237,000 |
| 11844841 |
Dosing regimens and related compositions and methods |
Federico Grossi, Cedric Francois, Patrick Johnson, Carolina Vega |
2023-12-19 |
$130,380,000 |
| 11712460 |
Methods of treating chronic disorders with complement inhibitors |
Cedric Francois |
2023-08-01 |
$52,633,000 |
| 11661441 |
Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof |
Cedric Francois |
2023-05-30 |
$139,687,000 |
| 11407789 |
Cell-penetrating compstatin analogs and uses thereof |
Cedric Francois, Monica Gerber |
2022-08-09 |
$117,290,000 |
| 11292815 |
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods |
Cedric Francois |
2022-04-05 |
$51,431,000 |
| 11291407 |
Detection of high risk drusen |
Cedric Francois |
2022-04-05 |
$51,431,000 |
| 11101026 |
Schedule-based electronic medical record modules, applications, and uses thereof |
Cedric Francois, Gaurav Bazaz, Alec Machiels, Monica Gerber |
2021-08-24 |
|
| 11040107 |
Dosing regimens and related compositions and methods |
Federico Grossi, Cedric Francois, Patrick Johnson, Carolina Vega |
2021-06-22 |
$69,645,000 |
| 11013782 |
Methods of treating chronic disorders with complement inhibitors |
Cedric Francois |
2021-05-25 |
$62,528,000 |
| 11001610 |
Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof |
Cedric Francois |
2021-05-11 |
$48,441,000 |
| 10941184 |
Cell-penetrating compstatin analogs and uses thereof |
Cedric Francois, Monica Gerber |
2021-03-09 |
$61,326,000 |
| 10875893 |
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods |
Cedric Francois |
2020-12-29 |
$74,198,000 |
| 10696718 |
Compstatin analogs for treatment of neuropathic pain |
Cedric Francois |
2020-06-30 |
$40,797,000 |
| 10407466 |
Methods of selecting compstatin mimetics |
Paul Olson, Cedric Francois |
2019-09-10 |
$27,178,000 |
| 10308687 |
Cell-penetrating compstatin analogs and uses thereof |
Cedric Francois, Monica Gerber |
2019-06-04 |
$20,138,000 |
| 10125171 |
Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof |
Cedric Francois |
2018-11-13 |
$14,888,000 |
| 10039802 |
Methods of treating chronic disorders with complement inhibitors |
Cedric Francois |
2018-08-07 |
$18,988,000 |
| 10035822 |
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods |
Cedric Francois |
2018-07-31 |
$18,643,000 |
| 9421240 |
Compstatin analogs for treatment of neuropathic pain |
Cedric Francois |
2016-08-23 |
|
| 9291622 |
Complement assays and uses thereof |
Zhouning Zhang, Cedric Francois, Paul Olson |
2016-03-22 |
|
| 9056076 |
Method of treating age-related macular degeneration comprising administering a compstatin analog |
Paul Olson, Cedric Francois |
2015-06-16 |
|
| 8580735 |
Local complement inhibition for treatment of complement-mediated disorders |
Cedric Francois, Paul Olson |
2013-11-12 |
|
